Navigation Links
Neogen reports 27% increase in quarterly net income
Date:3/26/2013

n

$1,812

$1,578$5,103

$4,489Interest income

33

30114

78Gross margin (% of sales)

53.5%

51.0%53.5%

50.6%Operating income (% of sales)

18.9%

16.8%20.1%

18.5%Revenue increase vs. FY 2012

13.7%11.8%Net income increase (decrease)vs. FY 2012

26.6%22.0% NEOGEN CORPORATION SUMMARIZED CONSOLIDATED BALANCE SHEET DATA(In thousands)Feb. 28May 3120132012(Unaudited)

(Audited)AssetsCurrent assetsCash & investments

$74,566

$68,645Accounts receivable

38,694

35,652Inventory

41,082

34,992Other current assets

5,729

4,652Total current assets

160,071

143,941Property & equipment

33,414

29,933Goodwill & other assets

87,540

77,726Total assets

$281,025

$251,600Liabilities & EquityCurrent liabilities

$22,569

$19,979Long-term debt

-

-Other non-current liabilities

12,758

12,567Equity: Shares outstanding23,922 in Feb. & 23,620 in May

245,698

219,054Total liabilities & equity

$281,025

$251,600Certain portions of this news release that do not relate to historical financial information constitute forward-looking statements. These forward-looking statements are subject to certain risks and uncertainties. Actual future results and trends may differ materially from historical results or those expected depending on a variety of factors listed in Management's Discussion and Analysis of Financial Condition and Results of Operations in the Company's most recently filed Form 10-K.

CONTACT:
Steven J. Quinlan
Vice President and CFO
517/372-9200


'/>"/>
SOURCE Neogen Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Neogen Corporation Announces 2nd Quarter Results Conference Call
2. Neogen Reports Second Quarter Results
3. Neogen Launches Fully Quantitative Lateral Flow Test for DON
4. Neogen launches the fastest molecular pathogen test
5. Neogen acquires Igenity from Merial
6. Neogen Corporation Announces Year-End Results Conference Call
7. Neogen reports year end results
8. Neogen Corporation Announces 1st Quarter Results Conference Call
9. Neogen reports 30% increase in quarterly net income
10. Neogen Corporation Announces 3rd Quarter Results Conference Call
11. Neogen launches rapid tests for ractopamine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2, 2015  RXi Pharmaceuticals Corporation (NASDAQ: ... on discovering and developing innovative therapies primarily ... today announced that Dr. Pamela Pavco , ... the 23 rd World Congress of ... include in-depth presentations by world-class clinicians and/or ...
(Date:6/2/2015)... 02, 2015 Through rare discovery of ... Yancy Corporation is enabling World Scientists to actually ... biological sample, displaying the full nature (position, shape, size, ... , Jeff Porter, Co-Founder of the Yancy Corporation, says, ... – rare. They come once in a lifetime, if ...
(Date:6/1/2015)... (PRWEB) June 02, 2015 Chosen ... health care, Jack Uldrich has been selected as ... New York today. He will deliver his keynote: ... Uldrich has delivered presentations to the American Medical ... Audiology and Neurology, Alcetel-Lucent/Verizon Forum on Wireless Healthcare, ...
(Date:6/1/2015)... and RARITAN, N.J. ... Development, LLC (Janssen) announced data from the Phase ... improvement in progression-free survival (PFS) with trabectedin (YONDELIS ... advanced liposarcoma (LPS) or leiomyosarcoma (LMS) previously treated ... chemotherapy regimen. SAR3007 is the largest randomized Phase ...
Breaking Biology Technology:RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 2RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 3RXi Pharmaceuticals to Present at the 23rd World Congress of Dermatology 4Scientists Eying Rare Discovery Of New Physics & Light Microscope Technology 2Futurist Jack Uldrich to Address the Future of Pharmaceuticals 2Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 2Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 3Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 4Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 5Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 6
... Mass., Sept. 22 Xenon Corp., a company,internationally recognized ... Pulsed,Light systems, might have found the silver bullet that ... fight against disease., It,s called Pulsed light. It,s ... on mushrooms -- increases the vitamin D content in,mushrooms ...
... of billions of cells that continually transmit signals to ... to learn, remember, and so much more − works ... in other words, when there is a good ,synapse,. ... protein production along with the synapse. VIB researchers connected ...
... 19 Boston Scientific,Corporation (NYSE: BSX ) is ... which is being held September 22 - 25 in ... Officer, will make a,30-minute presentation which will be followed ... 25, beginning at approximately 9:00,a.m. ET., A live ...
Cached Biology Technology:Massachusetts Company May Have Silver Bullet In Vitamin D Fight Against Disease 2Massachusetts Company May Have Silver Bullet In Vitamin D Fight Against Disease 3Revealing the regulating mechanism behind signal transduction in the brain 2
(Date:6/1/2015)... , June 1, 2015 ... Generation Biometrics Market by Application (Government, Military & ... & Immigration, and Security), Technology (Face Recognition, Fingerprint ... Recognition, Vein Recognition, and Others), Function (Contact and ... , Europe , APAC, Row) ...
(Date:5/26/2015)... Research and Markets ( ... "Saudi Arabia Biometric Systems Market Forecast and ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The biometric systems market in ... to grow at over 22% CAGR through 2020 ... the surging demand for better biometric technologies in ...
(Date:5/21/2015)... According to a new ... Software, Services), by Applications (Surveillance (Airborne, Maritime, Land), ... (Military & Defense & Commercial) - Global Forecast ... is expected to grow from $7252.0 Million in ... Compound Annual Growth Rate (CAGR) of 6.6%. ...
Breaking Biology News(10 mins):Next Generation Biometrics Market Worth $24,448.84 Million by 2020 2Next Generation Biometrics Market Worth $24,448.84 Million by 2020 3Next Generation Biometrics Market Worth $24,448.84 Million by 2020 4Saudi Arabia Biometric Systems Market Forecast and Opportunities, 2020 with Morpho Safran, ZK Technlogy, and Suprema Dominating 2Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4
... jaw of a 120 million year old marine reptile suggest that ... The healed bite wounds were probably made by a member of ... behaviour of extinct sea creatures from the time of dinosaurs. The ... Polonica . Found in the remote desert near the town ...
... when cosmetics, shampoos, skin creams, and other personal care ... to plant-derived extracts and other natural ingredients government ... the silicone-based ingredients long used in these products. That,s ... of Chemical & Engineering News (C&EN), ACS, weekly newsmagazine. ...
... providing the inspiration for University of Adelaide computer science ... increase wind farm productivity. Senior Lecturer Dr Frank ... a "selection of the fittest" step-by-step approach called "evolutionary ... account wake effects, the minimum amount of land needed, ...
Cached Biology News:Battle scars found on an ancient sea monster 2Evolutionary lessons for wind farm efficiency 2
... CELlulose) was developed in the late 1960s ... of the earliest commercial pioneers of immunoassay ... range in 1987. Sac-Cel rapidly found favour ... own "in house" radioimmunoassays, and became a ...
Determin interaction of your protein with Echelons lipids...
... Eppendorf Reference Series 2000 Pipette is a ... a compact and robust design, and superior ... used to operate the measuring stroke and ... Product features:Eppendorf "pipette/tip" system ensures utmost accuracy ...
Identify and characterize Phosphoinositide (PI(3,4,5)P3) binding...
Biology Products: